Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.53 USD | +2.12% | +26.35% | +77.16% |
Jun. 04 | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.16% | 637M | |
+18.30% | 123B | |
+14.73% | 107B | |
-4.60% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.24% | 16.23B | |
+2.41% | 13.43B | |
+23.60% | 11.32B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Mizuho Trims Price Target on Selecta Biosciences to $3 From $4, Maintains Buy Rating